| 0 |
NPM1 GENE MUTATION |
10 |
0.7143 |
| 1 |
INFECTIOUS CRYSTALLINE KERATOPATHY |
13 |
0.3514 |
| 2 |
ACANTHAMOEBA KERATITIS |
8 |
0.2162 |
| 3 |
SERPIGINOUS CHOROIDITIS |
8 |
0.1667 |
| 4 |
INFECTIVE KERATITIS |
10 |
0.1408 |
| 5 |
KERATITIS FUNGAL |
24 |
0.1154 |
| 6 |
CHIMERISM |
10 |
0.1124 |
| 7 |
CORNEAL EPITHELIUM DEFECT |
62 |
0.1067 |
| 8 |
CORNEAL GRAFT REJECTION |
21 |
0.1000 |
| 9 |
HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS |
7 |
0.0959 |
| 10 |
CORNEAL INFILTRATES |
29 |
0.0924 |
| 11 |
CHOROIDITIS |
33 |
0.0882 |
| 12 |
KERATITIS BACTERIAL |
14 |
0.0859 |
| 13 |
PERSISTENT CORNEAL EPITHELIAL DEFECT |
10 |
0.0847 |
| 14 |
TRACTIONAL RETINAL DETACHMENT |
9 |
0.0811 |
| 15 |
RECALLED PRODUCT ADMINISTERED |
764 |
0.0800 |
| 16 |
CONJUNCTIVAL ULCER |
11 |
0.0797 |
| 17 |
ANTERIOR CHAMBER FIBRIN |
10 |
0.0775 |
| 18 |
NECROTISING SCLERITIS |
10 |
0.0690 |
| 19 |
SCLERAL THINNING |
7 |
0.0660 |
| 20 |
CORNEAL TRANSPLANT |
51 |
0.0651 |
| 21 |
RHEGMATOGENOUS RETINAL DETACHMENT |
13 |
0.0622 |
| 22 |
CORNEAL THINNING |
15 |
0.0584 |
| 23 |
BRONCHIOLITIS OBLITERANS SYNDROME |
10 |
0.0571 |
| 24 |
TOXIC ANTERIOR SEGMENT SYNDROME |
62 |
0.0568 |
| 25 |
CORNEAL SCAR |
26 |
0.0517 |
| 26 |
ANTERIOR CHAMBER CELL |
36 |
0.0504 |
| 27 |
EYE OPERATION COMPLICATION |
8 |
0.0488 |
| 28 |
CORNEAL DEPOSITS |
34 |
0.0457 |
| 29 |
CORNEAL OPACITY |
62 |
0.0454 |
| 30 |
HYPOTONY OF EYE |
19 |
0.0452 |
| 31 |
FLAT ANTERIOR CHAMBER OF EYE |
8 |
0.0447 |
| 32 |
IRIS ATROPHY |
9 |
0.0435 |
| 33 |
CORNEAL OEDEMA |
96 |
0.0428 |
| 34 |
HYPOPYON |
35 |
0.0423 |
| 35 |
CATARACT SUBCAPSULAR |
25 |
0.0410 |
| 36 |
SCLERAL DISORDER |
11 |
0.0407 |
| 37 |
PUNCTATE KERATITIS |
37 |
0.0403 |
| 38 |
PERIORBITAL PAIN |
32 |
0.0378 |
| 39 |
DEAFNESS PERMANENT |
7 |
0.0357 |
| 40 |
CSF PRESSURE INCREASED |
9 |
0.0338 |
| 41 |
CORNEAL PERFORATION |
21 |
0.0333 |
| 42 |
FIBROUS HISTIOCYTOMA |
11 |
0.0313 |
| 43 |
EYELID PAIN |
63 |
0.0310 |
| 44 |
HYPHAEMA |
16 |
0.0307 |
| 45 |
ENDOPHTHALMITIS |
184 |
0.0306 |
| 46 |
CORNEAL DISORDER |
67 |
0.0305 |
| 47 |
NEOVASCULARISATION |
8 |
0.0304 |
| 48 |
FOREIGN BODY IN EYE |
28 |
0.0292 |
| 49 |
INJURY CORNEAL |
15 |
0.0288 |
| 50 |
EYE INFECTION FUNGAL |
11 |
0.0284 |
| 51 |
CORNEAL NEOVASCULARISATION |
7 |
0.0283 |
| 52 |
TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME |
7 |
0.0283 |
| 53 |
EYE INFECTION VIRAL |
9 |
0.0280 |
| 54 |
IRIS ADHESIONS |
14 |
0.0273 |
| 55 |
PRODUCT DROPPER ISSUE |
21 |
0.0267 |
| 56 |
INTRAOCULAR PRESSURE DECREASED |
14 |
0.0266 |
| 57 |
CYSTOID MACULAR OEDEMA |
48 |
0.0255 |
| 58 |
EPIRETINAL MEMBRANE |
7 |
0.0252 |
| 59 |
ACOUSTIC NEUROMA |
10 |
0.0244 |
| 60 |
ULCERATIVE KERATITIS |
67 |
0.0244 |
| 61 |
VITRECTOMY |
13 |
0.0218 |
| 62 |
NECROTISING RETINITIS |
13 |
0.0203 |
| 63 |
EYE INFECTION TOXOPLASMAL |
8 |
0.0202 |
| 64 |
SUPERFICIAL INJURY OF EYE |
22 |
0.0201 |
| 65 |
VITRITIS |
37 |
0.0200 |
| 66 |
FOREIGN BODY SENSATION IN EYES |
127 |
0.0199 |
| 67 |
COMPLICATIONS OF TRANSPLANT SURGERY |
10 |
0.0198 |
| 68 |
INTRAOCULAR PRESSURE INCREASED |
253 |
0.0198 |
| 69 |
OCULAR HYPERTENSION |
38 |
0.0196 |
| 70 |
ASTIGMATISM |
29 |
0.0191 |
| 71 |
CORNEAL ABRASION |
26 |
0.0190 |
| 72 |
CORYNEBACTERIUM INFECTION |
10 |
0.0187 |
| 73 |
VITREOUS OPACITIES |
15 |
0.0178 |
| 74 |
EYE ULCER |
10 |
0.0174 |
| 75 |
ENDOCRINE OPHTHALMOPATHY |
15 |
0.0173 |
| 76 |
SCLERITIS |
27 |
0.0168 |
| 77 |
IRITIS |
51 |
0.0168 |
| 78 |
RETINAL ISCHAEMIA |
10 |
0.0164 |
| 79 |
RETINAL PIGMENT EPITHELIOPATHY |
7 |
0.0162 |
| 80 |
EYE INFECTION BACTERIAL |
9 |
0.0161 |
| 81 |
KERATITIS |
48 |
0.0158 |
| 82 |
GLARE |
8 |
0.0156 |
| 83 |
TREATMENT FAILURE |
1267 |
0.0153 |
| 84 |
ANTERIOR CHAMBER INFLAMMATION |
9 |
0.0151 |
| 85 |
RETINAL VASCULITIS |
18 |
0.0151 |
| 86 |
PUPILLARY DISORDER |
9 |
0.0148 |
| 87 |
IRIDOCYCLITIS |
46 |
0.0145 |
| 88 |
CHOROIDAL DETACHMENT |
8 |
0.0144 |
| 89 |
EYE PAIN |
800 |
0.0142 |
| 90 |
KERATOPATHY |
22 |
0.0139 |
| 91 |
OPHTHALMIC HERPES SIMPLEX |
8 |
0.0139 |
| 92 |
HALO VISION |
15 |
0.0133 |
| 93 |
EYE INFLAMMATION |
124 |
0.0130 |
| 94 |
NON-INFECTIOUS ENDOPHTHALMITIS |
11 |
0.0130 |
| 95 |
CATARACT NUCLEAR |
8 |
0.0120 |
| 96 |
OCULAR DISCOMFORT |
133 |
0.0118 |
| 97 |
MACULAR FIBROSIS |
8 |
0.0118 |
| 98 |
OPEN ANGLE GLAUCOMA |
7 |
0.0114 |
| 99 |
INTRAOCULAR PRESSURE TEST ABNORMAL |
8 |
0.0113 |
| 100 |
UVEITIS |
154 |
0.0113 |
| 101 |
HERPES OPHTHALMIC |
14 |
0.0106 |
| 102 |
VITREOUS HAEMORRHAGE |
29 |
0.0105 |
| 103 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
21 |
0.0105 |
| 104 |
EPISCLERITIS |
7 |
0.0101 |
| 105 |
CHOROIDAL EFFUSION |
8 |
0.0100 |
| 106 |
PHOTOPHOBIA |
187 |
0.0099 |
| 107 |
PRODUCT LOT NUMBER ISSUE |
22 |
0.0099 |
| 108 |
BLADDER TRANSITIONAL CELL CARCINOMA |
14 |
0.0098 |
| 109 |
CONJUNCTIVAL OEDEMA |
10 |
0.0097 |
| 110 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
9 |
0.0095 |
| 111 |
EYE DISCHARGE |
93 |
0.0089 |
| 112 |
EYE OPERATION |
41 |
0.0089 |
| 113 |
BENIGN INTRACRANIAL HYPERTENSION |
11 |
0.0088 |
| 114 |
CYTOMEGALOVIRUS CHORIORETINITIS |
17 |
0.0087 |
| 115 |
STEROID DIABETES |
13 |
0.0087 |
| 116 |
EYE IRRITATION |
477 |
0.0083 |
| 117 |
RETINAL TEAR |
20 |
0.0081 |
| 118 |
PRODUCT EXPIRATION DATE ISSUE |
11 |
0.0078 |
| 119 |
OPHTHALMIC HERPES ZOSTER |
14 |
0.0078 |
| 120 |
ABNORMAL SENSATION IN EYE |
33 |
0.0077 |
| 121 |
PRODUCT DELIVERY MECHANISM ISSUE |
41 |
0.0076 |
| 122 |
CONJUNCTIVAL HYPERAEMIA |
27 |
0.0076 |
| 123 |
EYELID IRRITATION |
19 |
0.0076 |
| 124 |
RETINAL OEDEMA |
14 |
0.0073 |
| 125 |
OCULAR HYPERAEMIA |
343 |
0.0072 |
| 126 |
GLAUCOMA |
137 |
0.0071 |
| 127 |
MACULAR OEDEMA |
39 |
0.0070 |
| 128 |
RETINAL DETACHMENT |
63 |
0.0068 |
| 129 |
CONJUNCTIVITIS ALLERGIC |
10 |
0.0067 |
| 130 |
PRODUCT CONTAINER ISSUE |
57 |
0.0066 |
| 131 |
EYELID MARGIN CRUSTING |
19 |
0.0066 |
| 132 |
VISUAL ACUITY REDUCED |
212 |
0.0064 |
| 133 |
SWELLING OF EYELID |
40 |
0.0064 |
| 134 |
EYE INFECTION |
71 |
0.0063 |
| 135 |
ANGLE CLOSURE GLAUCOMA |
16 |
0.0063 |
| 136 |
LIQUID PRODUCT PHYSICAL ISSUE |
44 |
0.0060 |
| 137 |
ESSENTIAL HYPERTENSION |
11 |
0.0060 |
| 138 |
VITREOUS FLOATERS |
59 |
0.0060 |
| 139 |
BLINDNESS UNILATERAL |
81 |
0.0057 |
| 140 |
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION |
8 |
0.0057 |
| 141 |
INCORRECT DOSE ADMINISTERED BY PRODUCT |
9 |
0.0056 |
| 142 |
VITREOUS DETACHMENT |
12 |
0.0055 |
| 143 |
METAMORPHOPSIA |
10 |
0.0054 |
| 144 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
11 |
0.0053 |
| 145 |
TRANSPLANT FAILURE |
13 |
0.0053 |
| 146 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
12 |
0.0053 |
| 147 |
BLEPHARITIS |
21 |
0.0052 |
| 148 |
RADIATION PNEUMONITIS |
11 |
0.0051 |
| 149 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
11 |
0.0051 |
| 150 |
DRUG DELIVERY SYSTEM ISSUE |
10 |
0.0051 |
| 151 |
CYTOMEGALOVIRUS TEST POSITIVE |
9 |
0.0050 |
| 152 |
LIVER TRANSPLANT REJECTION |
9 |
0.0050 |
| 153 |
LACRIMATION INCREASED |
151 |
0.0050 |
| 154 |
NEPHROGENIC ANAEMIA |
23 |
0.0050 |
| 155 |
OPTIC ATROPHY |
8 |
0.0049 |
| 156 |
CATARACT OPERATION |
29 |
0.0049 |
| 157 |
DEAFNESS NEUROSENSORY |
16 |
0.0049 |
| 158 |
DISLOCATION OF VERTEBRA |
11 |
0.0048 |
| 159 |
MEDICATION RESIDUE PRESENT |
23 |
0.0048 |
| 160 |
CATARACT |
286 |
0.0048 |
| 161 |
RECALLED PRODUCT |
8 |
0.0046 |
| 162 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
8 |
0.0045 |
| 163 |
EYE ALLERGY |
7 |
0.0045 |
| 164 |
PRODUCT DEPOSIT |
7 |
0.0045 |
| 165 |
EYE SWELLING |
167 |
0.0045 |
| 166 |
BLOOD IMMUNOGLOBULIN G DECREASED |
11 |
0.0044 |
| 167 |
DUODENAL ULCER PERFORATION |
33 |
0.0044 |
| 168 |
HYPERPARATHYROIDISM SECONDARY |
11 |
0.0044 |
| 169 |
MUSCLE INJURY |
36 |
0.0043 |
| 170 |
PRODUCT CONTAMINATION PHYSICAL |
11 |
0.0043 |
| 171 |
BREAST CANCER STAGE III |
28 |
0.0043 |
| 172 |
PERIPHERAL VENOUS DISEASE |
17 |
0.0042 |
| 173 |
HELICOBACTER INFECTION |
42 |
0.0041 |
| 174 |
EYE OEDEMA |
10 |
0.0041 |
| 175 |
PERIORBITAL SWELLING |
23 |
0.0041 |
| 176 |
TREATMENT DELAYED |
7 |
0.0040 |
| 177 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
11 |
0.0040 |
| 178 |
PANCREATIC FAILURE |
7 |
0.0040 |
| 179 |
RETINAL ARTERY OCCLUSION |
10 |
0.0040 |
| 180 |
EYE INJURY |
12 |
0.0039 |
| 181 |
ERYTHEMA OF EYELID |
21 |
0.0039 |
| 182 |
RETINAL DISORDER |
10 |
0.0038 |
| 183 |
NO ADVERSE EVENT |
682 |
0.0038 |
| 184 |
CONJUNCTIVAL HAEMORRHAGE |
14 |
0.0037 |
| 185 |
INSTILLATION SITE PAIN |
9 |
0.0036 |
| 186 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
8 |
0.0036 |
| 187 |
TRANSPLANT REJECTION |
28 |
0.0035 |
| 188 |
HORDEOLUM |
15 |
0.0035 |
| 189 |
EYE DISORDER |
113 |
0.0034 |
| 190 |
VISION BLURRED |
470 |
0.0034 |
| 191 |
OPTIC NEUROPATHY |
7 |
0.0033 |
| 192 |
THROMBOCYTOSIS |
12 |
0.0033 |
| 193 |
DRY EYE |
162 |
0.0032 |
| 194 |
IMMOBILE |
14 |
0.0032 |
| 195 |
HAND DEFORMITY |
42 |
0.0032 |
| 196 |
BLOOD BLISTER |
10 |
0.0032 |
| 197 |
CONJUNCTIVITIS |
59 |
0.0032 |
| 198 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
8 |
0.0031 |
| 199 |
KIDNEY TRANSPLANT REJECTION |
15 |
0.0031 |
| 200 |
MACULOPATHY |
11 |
0.0031 |
| 201 |
PAPILLOEDEMA |
14 |
0.0031 |
| 202 |
BLINDNESS |
126 |
0.0031 |
| 203 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
22 |
0.0031 |
| 204 |
FACIAL PAIN |
27 |
0.0030 |
| 205 |
BLOOD CULTURE POSITIVE |
9 |
0.0030 |
| 206 |
PHOTOPSIA |
19 |
0.0030 |
| 207 |
PEMPHIGUS |
37 |
0.0030 |
| 208 |
EXOSTOSIS |
27 |
0.0030 |
| 209 |
RETINOPATHY |
11 |
0.0029 |
| 210 |
ASTHENOPIA |
16 |
0.0029 |
| 211 |
HYPERCHOLESTEROLAEMIA |
28 |
0.0029 |
| 212 |
SERUM SICKNESS |
8 |
0.0029 |
| 213 |
EYE HAEMORRHAGE |
38 |
0.0028 |
| 214 |
IMMUNOSUPPRESSION |
25 |
0.0028 |
| 215 |
IMPAIRED HEALING |
91 |
0.0028 |
| 216 |
AUTOIMMUNE DISORDER |
27 |
0.0028 |
| 217 |
EYE PRURITUS |
93 |
0.0028 |
| 218 |
LIP DRY |
25 |
0.0027 |
| 219 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
15 |
0.0027 |
| 220 |
RHEUMATIC FEVER |
12 |
0.0027 |
| 221 |
PRODUCT USE COMPLAINT |
42 |
0.0027 |
| 222 |
DIABETIC RETINOPATHY |
9 |
0.0026 |
| 223 |
NAIL DISORDER |
23 |
0.0026 |
| 224 |
FIBROSIS |
8 |
0.0026 |
| 225 |
PRODUCT RESIDUE PRESENT |
14 |
0.0026 |
| 226 |
GASTRIC PERFORATION |
7 |
0.0026 |
| 227 |
DYSLIPIDAEMIA |
13 |
0.0026 |
| 228 |
INFUSION SITE PRURITUS |
8 |
0.0025 |
| 229 |
JOINT RANGE OF MOTION DECREASED |
34 |
0.0025 |
| 230 |
PRODUCT ADMINISTRATION ERROR |
51 |
0.0025 |
| 231 |
FOLLICULITIS |
26 |
0.0025 |
| 232 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
16 |
0.0025 |
| 233 |
RETINAL VEIN OCCLUSION |
7 |
0.0024 |
| 234 |
RETINAL HAEMORRHAGE |
17 |
0.0024 |
| 235 |
INFUSION SITE SWELLING |
15 |
0.0024 |
| 236 |
GRAFT VERSUS HOST DISEASE |
17 |
0.0024 |
| 237 |
EYELID PTOSIS |
24 |
0.0024 |
| 238 |
BLINDNESS TRANSIENT |
17 |
0.0023 |
| 239 |
DIVERTICULUM INTESTINAL |
10 |
0.0023 |
| 240 |
GRIP STRENGTH DECREASED |
20 |
0.0023 |
| 241 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
17 |
0.0023 |
| 242 |
PHYSICAL DISABILITY |
10 |
0.0023 |
| 243 |
VISUAL IMPAIRMENT |
279 |
0.0022 |
| 244 |
RHEUMATOID FACTOR POSITIVE |
13 |
0.0022 |
| 245 |
PRODUCT CONTAMINATION |
8 |
0.0022 |
| 246 |
CUTANEOUS VASCULITIS |
8 |
0.0022 |
| 247 |
PNEUMONIA BACTERIAL |
20 |
0.0022 |
| 248 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
11 |
0.0022 |
| 249 |
BACTERIAL SEPSIS |
7 |
0.0021 |
| 250 |
GLOSSODYNIA |
48 |
0.0021 |
| 251 |
HAEMODIALYSIS |
18 |
0.0021 |
| 252 |
PRODUCT COLOUR ISSUE |
11 |
0.0021 |
| 253 |
ATRIAL FLUTTER |
17 |
0.0021 |
| 254 |
INFUSION SITE HAEMORRHAGE |
7 |
0.0021 |
| 255 |
VAGINAL INFECTION |
10 |
0.0021 |
| 256 |
SKIN ABRASION |
10 |
0.0021 |
| 257 |
INCORRECT DRUG ADMINISTRATION RATE |
9 |
0.0021 |
| 258 |
PSEUDOMONAS INFECTION |
18 |
0.0021 |
| 259 |
OBESITY |
33 |
0.0021 |
| 260 |
THROMBOTIC MICROANGIOPATHY |
20 |
0.0021 |
| 261 |
IRRITABLE BOWEL SYNDROME |
44 |
0.0021 |
| 262 |
CONTRAINDICATED PRODUCT ADMINISTERED |
61 |
0.0020 |
| 263 |
CYTOMEGALOVIRUS INFECTION |
33 |
0.0020 |
| 264 |
CYSTITIS HAEMORRHAGIC |
8 |
0.0020 |
| 265 |
BONE EROSION |
7 |
0.0020 |
| 266 |
EYELID OEDEMA |
23 |
0.0020 |
| 267 |
KLEBSIELLA INFECTION |
10 |
0.0020 |
| 268 |
UROSEPSIS |
18 |
0.0019 |
| 269 |
CHRONIC GRAFT VERSUS HOST DISEASE |
7 |
0.0019 |
| 270 |
SPINAL STENOSIS |
8 |
0.0019 |
| 271 |
LIVE BIRTH |
16 |
0.0019 |
| 272 |
PARADOXICAL DRUG REACTION |
7 |
0.0019 |
| 273 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
21 |
0.0019 |
| 274 |
PARANASAL SINUS DISCOMFORT |
7 |
0.0018 |
| 275 |
HAEMORRHOIDAL HAEMORRHAGE |
9 |
0.0018 |
| 276 |
DIVERTICULUM |
13 |
0.0018 |
| 277 |
OPTIC ISCHAEMIC NEUROPATHY |
7 |
0.0018 |
| 278 |
PULMONARY ALVEOLAR HAEMORRHAGE |
10 |
0.0018 |
| 279 |
PRODUCT LEAKAGE |
10 |
0.0018 |
| 280 |
TRISMUS |
9 |
0.0017 |
| 281 |
MALIGNANT MELANOMA |
23 |
0.0017 |
| 282 |
FOOT DEFORMITY |
19 |
0.0017 |
| 283 |
SEASONAL ALLERGY |
24 |
0.0017 |
| 284 |
BLOOD IRON DECREASED |
20 |
0.0017 |
| 285 |
THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION |
7 |
0.0017 |
| 286 |
BRONCHOPULMONARY ASPERGILLOSIS |
13 |
0.0017 |
| 287 |
ASPERGILLUS INFECTION |
11 |
0.0017 |
| 288 |
OSTEOARTHRITIS |
71 |
0.0017 |
| 289 |
VISUAL FIELD DEFECT |
12 |
0.0017 |
| 290 |
ADRENAL INSUFFICIENCY |
20 |
0.0016 |
| 291 |
WOUND INFECTION |
18 |
0.0016 |
| 292 |
PRODUCT DISPENSING ISSUE |
7 |
0.0016 |
| 293 |
HAEMATOCRIT DECREASED |
32 |
0.0016 |
| 294 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
14 |
0.0016 |
| 295 |
BLEPHAROSPASM |
10 |
0.0016 |
| 296 |
EAR INFECTION |
42 |
0.0016 |
| 297 |
SUSPECTED OFF LABEL USE |
7 |
0.0015 |
| 298 |
THERAPY PARTIAL RESPONDER |
24 |
0.0015 |
| 299 |
TENDERNESS |
16 |
0.0015 |
| 300 |
INFLAMMATION |
79 |
0.0015 |
| 301 |
HYPOGAMMAGLOBULINAEMIA |
10 |
0.0015 |
| 302 |
ORAL CANDIDIASIS |
20 |
0.0015 |
| 303 |
POST PROCEDURAL COMPLICATION |
29 |
0.0015 |
| 304 |
LOWER LIMB FRACTURE |
29 |
0.0015 |
| 305 |
POST PROCEDURAL INFECTION |
12 |
0.0015 |
| 306 |
PRODUCT LABEL ISSUE |
10 |
0.0015 |
| 307 |
PRODUCT PACKAGING ISSUE |
14 |
0.0015 |
| 308 |
HYDRONEPHROSIS |
11 |
0.0015 |
| 309 |
LIVER INJURY |
36 |
0.0015 |
| 310 |
CONCOMITANT DISEASE AGGRAVATED |
9 |
0.0015 |
| 311 |
JOINT EFFUSION |
10 |
0.0014 |
| 312 |
ATELECTASIS |
14 |
0.0014 |
| 313 |
ENTEROCOCCAL INFECTION |
7 |
0.0014 |
| 314 |
STREPTOCOCCAL INFECTION |
8 |
0.0014 |
| 315 |
STAPHYLOCOCCAL SEPSIS |
7 |
0.0014 |
| 316 |
SINUS CONGESTION |
19 |
0.0014 |
| 317 |
MULTIPLE ALLERGIES |
11 |
0.0014 |
| 318 |
BURSITIS |
17 |
0.0014 |
| 319 |
BACTERIAL INFECTION |
26 |
0.0014 |
| 320 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
22 |
0.0014 |
| 321 |
LOW BIRTH WEIGHT BABY |
11 |
0.0014 |
| 322 |
RALES |
8 |
0.0014 |
| 323 |
END STAGE RENAL DISEASE |
25 |
0.0014 |
| 324 |
PERICARDITIS |
23 |
0.0014 |
| 325 |
FAILURE TO THRIVE |
7 |
0.0013 |
| 326 |
ESCHERICHIA INFECTION |
11 |
0.0013 |
| 327 |
BLOOD LACTIC ACID INCREASED |
7 |
0.0013 |
| 328 |
SCIATICA |
21 |
0.0013 |
| 329 |
ECCHYMOSIS |
9 |
0.0013 |
| 330 |
INFUSION SITE ERYTHEMA |
11 |
0.0013 |
| 331 |
DIFFUSE LARGE B-CELL LYMPHOMA |
10 |
0.0013 |
| 332 |
DECREASED ACTIVITY |
14 |
0.0013 |
| 333 |
ELECTROLYTE IMBALANCE |
15 |
0.0013 |
| 334 |
OSTEOPOROSIS |
53 |
0.0013 |
| 335 |
VITAMIN D DECREASED |
11 |
0.0013 |
| 336 |
FLANK PAIN |
12 |
0.0013 |
| 337 |
SYNOVITIS |
23 |
0.0013 |
| 338 |
NEUTROPHIL COUNT INCREASED |
13 |
0.0013 |
| 339 |
FOOT FRACTURE |
24 |
0.0013 |
| 340 |
DISABILITY |
25 |
0.0013 |
| 341 |
DEVICE USE ISSUE |
22 |
0.0013 |
| 342 |
SUPRAVENTRICULAR TACHYCARDIA |
12 |
0.0013 |
| 343 |
IMPAIRED QUALITY OF LIFE |
18 |
0.0013 |
| 344 |
MYDRIASIS |
16 |
0.0012 |
| 345 |
ROTATOR CUFF SYNDROME |
16 |
0.0012 |
| 346 |
DISCOMFORT |
76 |
0.0012 |
| 347 |
INFUSION SITE PAIN |
16 |
0.0012 |
| 348 |
FIBROMYALGIA |
30 |
0.0012 |
| 349 |
POOR QUALITY PRODUCT ADMINISTERED |
13 |
0.0012 |
| 350 |
DIPLOPIA |
32 |
0.0012 |
| 351 |
MAJOR DEPRESSION |
9 |
0.0012 |
| 352 |
HERPES SIMPLEX |
8 |
0.0012 |
| 353 |
SHOCK HAEMORRHAGIC |
10 |
0.0012 |
| 354 |
GASTROINTESTINAL INFECTION |
11 |
0.0012 |
| 355 |
CYTOPENIA |
15 |
0.0012 |
| 356 |
CHRONIC KIDNEY DISEASE |
93 |
0.0012 |
| 357 |
BEDRIDDEN |
16 |
0.0012 |
| 358 |
BODY HEIGHT DECREASED |
13 |
0.0012 |
| 359 |
MOUTH SWELLING |
7 |
0.0012 |
| 360 |
SINUS DISORDER |
24 |
0.0012 |
| 361 |
PANCREATITIS ACUTE |
27 |
0.0012 |
| 362 |
PNEUMOTHORAX |
19 |
0.0012 |
| 363 |
BACTERAEMIA |
14 |
0.0012 |
| 364 |
NIGHT SWEATS |
38 |
0.0012 |
| 365 |
THERAPY NON-RESPONDER |
53 |
0.0012 |
| 366 |
INFUSION RELATED REACTION |
78 |
0.0012 |
| 367 |
MYELODYSPLASTIC SYNDROME |
17 |
0.0012 |
| 368 |
HYPERLIPIDAEMIA |
14 |
0.0012 |
| 369 |
RENAL FAILURE CHRONIC |
9 |
0.0012 |
| 370 |
LEUKOCYTOSIS |
21 |
0.0012 |
| 371 |
SQUAMOUS CELL CARCINOMA OF SKIN |
7 |
0.0012 |
| 372 |
NEURALGIA |
28 |
0.0012 |
| 373 |
INGUINAL HERNIA |
7 |
0.0011 |
| 374 |
MITRAL VALVE INCOMPETENCE |
13 |
0.0011 |
| 375 |
DRUG-INDUCED LIVER INJURY |
36 |
0.0011 |
| 376 |
GROIN PAIN |
10 |
0.0011 |
| 377 |
SPINAL OSTEOARTHRITIS |
10 |
0.0011 |
| 378 |
CHOLANGITIS |
7 |
0.0011 |
| 379 |
PHARYNGITIS |
14 |
0.0011 |
| 380 |
BLOOD PRESSURE SYSTOLIC INCREASED |
22 |
0.0011 |
| 381 |
SINUSITIS |
115 |
0.0011 |
| 382 |
RENAL TUBULAR NECROSIS |
11 |
0.0011 |
| 383 |
EPSTEIN-BARR VIRUS INFECTION |
7 |
0.0011 |
| 384 |
INTERSTITIAL LUNG DISEASE |
54 |
0.0011 |
| 385 |
PANCYTOPENIA |
62 |
0.0011 |
| 386 |
COLITIS ULCERATIVE |
49 |
0.0011 |
| 387 |
SECOND PRIMARY MALIGNANCY |
9 |
0.0011 |
| 388 |
EPILEPSY |
33 |
0.0011 |
| 389 |
OBSTRUCTIVE AIRWAYS DISORDER |
12 |
0.0011 |
| 390 |
SENSATION OF FOREIGN BODY |
9 |
0.0011 |
| 391 |
ARTERIOSCLEROSIS CORONARY ARTERY |
7 |
0.0011 |
| 392 |
APPETITE DISORDER |
7 |
0.0011 |
| 393 |
SKIN HYPERPIGMENTATION |
9 |
0.0010 |
| 394 |
ANURIA |
9 |
0.0010 |
| 395 |
LEFT VENTRICULAR DYSFUNCTION |
7 |
0.0010 |
| 396 |
MOUTH ULCERATION |
22 |
0.0010 |
| 397 |
HEPATIC ENZYME INCREASED |
71 |
0.0010 |
| 398 |
FEBRILE NEUTROPENIA |
69 |
0.0010 |
| 399 |
BRONCHIECTASIS |
7 |
0.0010 |
| 400 |
SINUS BRADYCARDIA |
10 |
0.0010 |
| 401 |
STAPHYLOCOCCAL INFECTION |
34 |
0.0010 |
| 402 |
HYPOALBUMINAEMIA |
8 |
0.0010 |
| 403 |
VITAMIN D DEFICIENCY |
10 |
0.0010 |
| 404 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
7 |
0.0010 |
| 405 |
STOMATITIS |
62 |
0.0010 |
| 406 |
TRICUSPID VALVE INCOMPETENCE |
8 |
0.0010 |
| 407 |
GINGIVAL PAIN |
8 |
0.0010 |
| 408 |
MACULAR DEGENERATION |
12 |
0.0010 |
| 409 |
TOOTH FRACTURE |
11 |
0.0010 |
| 410 |
CYTOKINE RELEASE SYNDROME |
20 |
0.0010 |
| 411 |
UPPER RESPIRATORY TRACT INFECTION |
46 |
0.0010 |
| 412 |
FUNGAL INFECTION |
33 |
0.0010 |
| 413 |
ACUTE RESPIRATORY FAILURE |
19 |
0.0010 |
| 414 |
LUNG DISORDER |
48 |
0.0010 |
| 415 |
GLOMERULAR FILTRATION RATE DECREASED |
12 |
0.0010 |
| 416 |
EAR DISCOMFORT |
10 |
0.0010 |
| 417 |
UPPER-AIRWAY COUGH SYNDROME |
8 |
0.0010 |
| 418 |
DERMATITIS CONTACT |
11 |
0.0010 |
| 419 |
NEPHROPATHY |
9 |
0.0010 |
| 420 |
FAECES SOFT |
7 |
0.0010 |
| 421 |
HEAD DISCOMFORT |
17 |
0.0010 |
| 422 |
FRACTURE |
18 |
0.0009 |
| 423 |
BLOOD PRESSURE DIASTOLIC DECREASED |
7 |
0.0009 |
| 424 |
CONDITION AGGRAVATED |
288 |
0.0009 |
| 425 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
7 |
0.0009 |
| 426 |
ARTHROPOD BITE |
7 |
0.0009 |
| 427 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
13 |
0.0009 |
| 428 |
SLEEP APNOEA SYNDROME |
18 |
0.0009 |
| 429 |
GASTROENTERITIS VIRAL |
17 |
0.0009 |
| 430 |
RESTLESS LEGS SYNDROME |
17 |
0.0009 |
| 431 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
51 |
0.0009 |
| 432 |
BLISTER |
52 |
0.0009 |
| 433 |
MUSCLE STRAIN |
8 |
0.0009 |
| 434 |
ECONOMIC PROBLEM |
14 |
0.0009 |
| 435 |
LOWER RESPIRATORY TRACT INFECTION |
42 |
0.0009 |
| 436 |
OSTEOPENIA |
14 |
0.0009 |
| 437 |
RESPIRATORY TRACT INFECTION |
24 |
0.0009 |
| 438 |
INFLAMMATORY BOWEL DISEASE |
9 |
0.0009 |
| 439 |
RENAL FAILURE |
122 |
0.0009 |
| 440 |
POLYNEUROPATHY |
11 |
0.0009 |
| 441 |
DRUG DISPENSING ERROR |
14 |
0.0009 |
| 442 |
PULMONARY HYPERTENSION |
19 |
0.0009 |
| 443 |
HOSPICE CARE |
9 |
0.0009 |
| 444 |
TUMOUR LYSIS SYNDROME |
8 |
0.0009 |
| 445 |
HYPOXIA |
32 |
0.0009 |
| 446 |
LYMPHOMA |
14 |
0.0009 |
| 447 |
PURPURA |
8 |
0.0009 |
| 448 |
CONCUSSION |
7 |
0.0009 |
| 449 |
ARTHROPATHY |
50 |
0.0009 |
| 450 |
TOOTH DISORDER |
20 |
0.0009 |
| 451 |
COLITIS |
34 |
0.0009 |
| 452 |
PULMONARY HAEMORRHAGE |
7 |
0.0009 |
| 453 |
ELECTROCARDIOGRAM ABNORMAL |
7 |
0.0009 |
| 454 |
JOINT INJURY |
19 |
0.0009 |
| 455 |
HERPES ZOSTER |
51 |
0.0009 |
| 456 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
22 |
0.0009 |
| 457 |
ILEUS |
11 |
0.0009 |
| 458 |
ASPARTATE AMINOTRANSFERASE INCREASED |
47 |
0.0009 |
| 459 |
THERAPY INTERRUPTED |
63 |
0.0009 |
| 460 |
RENAL CYST |
7 |
0.0009 |
| 461 |
PULMONARY MASS |
13 |
0.0009 |
| 462 |
TINNITUS |
40 |
0.0009 |
| 463 |
LOCALISED INFECTION |
21 |
0.0009 |
| 464 |
RHINITIS |
7 |
0.0009 |
| 465 |
IRON DEFICIENCY ANAEMIA |
8 |
0.0009 |
| 466 |
DELIRIUM |
30 |
0.0009 |
| 467 |
OFF LABEL USE |
750 |
0.0009 |
| 468 |
HYPERKALAEMIA |
30 |
0.0009 |
| 469 |
TUBULOINTERSTITIAL NEPHRITIS |
16 |
0.0009 |
| 470 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
41 |
0.0009 |
| 471 |
HICCUPS |
7 |
0.0009 |
| 472 |
INSURANCE ISSUE |
13 |
0.0008 |
| 473 |
SQUAMOUS CELL CARCINOMA |
8 |
0.0008 |
| 474 |
HIATUS HERNIA |
11 |
0.0008 |
| 475 |
CLOSTRIDIUM DIFFICILE COLITIS |
9 |
0.0008 |
| 476 |
PHARMACEUTICAL PRODUCT COMPLAINT |
22 |
0.0008 |
| 477 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
30 |
0.0008 |
| 478 |
HYPOKALAEMIA |
39 |
0.0008 |
| 479 |
TENDONITIS |
13 |
0.0008 |
| 480 |
BLOOD UREA INCREASED |
14 |
0.0008 |
| 481 |
INFECTION |
121 |
0.0008 |
| 482 |
RHINORRHOEA |
54 |
0.0008 |
| 483 |
JOINT SWELLING |
100 |
0.0008 |
| 484 |
HEAD INJURY |
26 |
0.0008 |
| 485 |
URINARY TRACT INFECTION |
140 |
0.0008 |
| 486 |
HAEMORRHOIDS |
16 |
0.0008 |
| 487 |
HEPATOMEGALY |
8 |
0.0008 |
| 488 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
18 |
0.0008 |
| 489 |
BLOOD MAGNESIUM DECREASED |
7 |
0.0008 |
| 490 |
HYPERCALCAEMIA |
10 |
0.0008 |
| 491 |
NERVE INJURY |
9 |
0.0008 |
| 492 |
LIGAMENT SPRAIN |
8 |
0.0008 |
| 493 |
PYELONEPHRITIS |
7 |
0.0008 |
| 494 |
MATERNAL EXPOSURE DURING PREGNANCY |
72 |
0.0008 |
| 495 |
ORAL PAIN |
18 |
0.0008 |
| 496 |
SNEEZING |
18 |
0.0008 |
| 497 |
PRESCRIBED UNDERDOSE |
16 |
0.0008 |
| 498 |
BACK DISORDER |
13 |
0.0008 |
| 499 |
HEPATIC CIRRHOSIS |
15 |
0.0008 |
| 500 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
8 |
0.0008 |
| 501 |
MOBILITY DECREASED |
57 |
0.0008 |
| 502 |
LIVER FUNCTION TEST INCREASED |
17 |
0.0008 |
| 503 |
TOXIC EPIDERMAL NECROLYSIS |
12 |
0.0008 |
| 504 |
PROTEINURIA |
15 |
0.0008 |
| 505 |
ARTHRITIS |
62 |
0.0008 |
| 506 |
PLATELET COUNT DECREASED |
84 |
0.0008 |
| 507 |
DRUG LEVEL DECREASED |
8 |
0.0008 |
| 508 |
RIB FRACTURE |
16 |
0.0008 |
| 509 |
HIP FRACTURE |
25 |
0.0008 |
| 510 |
PAIN IN JAW |
22 |
0.0008 |
| 511 |
DRUG INTOLERANCE |
75 |
0.0008 |
| 512 |
PRODUCT DOSE OMISSION ISSUE |
228 |
0.0008 |
| 513 |
VENTRICULAR EXTRASYSTOLES |
8 |
0.0008 |
| 514 |
ACUTE MYELOID LEUKAEMIA |
12 |
0.0008 |
| 515 |
HYPERTENSION |
163 |
0.0008 |
| 516 |
HEART RATE DECREASED |
27 |
0.0008 |
| 517 |
SPLENOMEGALY |
9 |
0.0008 |
| 518 |
ALANINE AMINOTRANSFERASE INCREASED |
47 |
0.0008 |
| 519 |
COVID-19 PNEUMONIA |
9 |
0.0008 |
| 520 |
INCREASED TENDENCY TO BRUISE |
7 |
0.0008 |
| 521 |
HYPERSENSITIVITY |
141 |
0.0008 |
| 522 |
SCRATCH |
8 |
0.0008 |
| 523 |
RESPIRATORY TRACT CONGESTION |
12 |
0.0008 |
| 524 |
BLOOD PRESSURE ABNORMAL |
15 |
0.0008 |
| 525 |
RESPIRATORY FAILURE |
55 |
0.0008 |
| 526 |
RENAL FAILURE ACUTE |
32 |
0.0008 |
| 527 |
MULTI-ORGAN FAILURE |
13 |
0.0008 |
| 528 |
WOUND |
21 |
0.0008 |
| 529 |
ATRIAL FIBRILLATION |
73 |
0.0007 |
| 530 |
QUALITY OF LIFE DECREASED |
10 |
0.0007 |
| 531 |
MUSCULOSKELETAL PAIN |
39 |
0.0007 |
| 532 |
SEPSIS |
83 |
0.0007 |
| 533 |
DYSPNOEA EXERTIONAL |
28 |
0.0007 |
| 534 |
CEREBRAL INFARCTION |
18 |
0.0007 |
| 535 |
DISEASE RECURRENCE |
35 |
0.0007 |
| 536 |
SKIN LACERATION |
8 |
0.0007 |
| 537 |
PERICARDIAL EFFUSION |
17 |
0.0007 |
| 538 |
PRODUCT DISPENSING ERROR |
16 |
0.0007 |
| 539 |
RED BLOOD CELL COUNT DECREASED |
21 |
0.0007 |
| 540 |
PULMONARY THROMBOSIS |
8 |
0.0007 |
| 541 |
ENCEPHALOPATHY |
18 |
0.0007 |
| 542 |
ACUTE KIDNEY INJURY |
112 |
0.0007 |
| 543 |
BLOOD POTASSIUM DECREASED |
22 |
0.0007 |
| 544 |
MELAENA |
16 |
0.0007 |
| 545 |
SLEEP DISORDER |
51 |
0.0007 |
| 546 |
LIVER DISORDER |
32 |
0.0007 |
| 547 |
DRUG INEFFECTIVE |
951 |
0.0007 |
| 548 |
RECTAL HAEMORRHAGE |
31 |
0.0007 |
| 549 |
EAR PAIN |
14 |
0.0007 |
| 550 |
OSTEOMYELITIS |
13 |
0.0007 |
| 551 |
MALNUTRITION |
8 |
0.0007 |
| 552 |
CARPAL TUNNEL SYNDROME |
10 |
0.0007 |
| 553 |
BLOOD CALCIUM DECREASED |
8 |
0.0007 |
| 554 |
DISSEMINATED INTRAVASCULAR COAGULATION |
10 |
0.0007 |
| 555 |
PLEURAL EFFUSION |
43 |
0.0007 |
| 556 |
SWELLING FACE |
46 |
0.0007 |
| 557 |
OEDEMA PERIPHERAL |
86 |
0.0007 |
| 558 |
HYPOPHAGIA |
18 |
0.0007 |
| 559 |
BRONCHITIS |
52 |
0.0007 |
| 560 |
SCAR |
12 |
0.0007 |
| 561 |
LIMB INJURY |
19 |
0.0007 |
| 562 |
HEPATIC FUNCTION ABNORMAL |
26 |
0.0007 |
| 563 |
EMPHYSEMA |
7 |
0.0007 |
| 564 |
WHEEZING |
41 |
0.0007 |
| 565 |
TASTE DISORDER |
14 |
0.0007 |
| 566 |
PNEUMONIA |
223 |
0.0007 |
| 567 |
TOOTH ABSCESS |
7 |
0.0007 |
| 568 |
MUSCULAR WEAKNESS |
78 |
0.0007 |
| 569 |
INTENTIONAL PRODUCT USE ISSUE |
60 |
0.0007 |
| 570 |
SPINAL PAIN |
8 |
0.0007 |
| 571 |
GASTROINTESTINAL HAEMORRHAGE |
57 |
0.0007 |
| 572 |
HAEMOGLOBIN DECREASED |
70 |
0.0007 |
| 573 |
POOR VENOUS ACCESS |
7 |
0.0007 |
| 574 |
CONTUSION |
65 |
0.0007 |
| 575 |
BLOOD PRESSURE INCREASED |
103 |
0.0007 |
| 576 |
PRESCRIBED OVERDOSE |
13 |
0.0007 |
| 577 |
PETECHIAE |
7 |
0.0007 |
| 578 |
IMMUNODEFICIENCY |
10 |
0.0007 |
| 579 |
PRODUCT USE ISSUE |
126 |
0.0007 |
| 580 |
PRODUCT TASTE ABNORMAL |
9 |
0.0007 |
| 581 |
OEDEMA |
36 |
0.0007 |
| 582 |
NEUROPATHY PERIPHERAL |
63 |
0.0007 |
| 583 |
JOINT DISLOCATION |
7 |
0.0007 |
| 584 |
TACHYPNOEA |
9 |
0.0007 |
| 585 |
NASOPHARYNGITIS |
122 |
0.0007 |
| 586 |
VIRAL INFECTION |
22 |
0.0007 |
| 587 |
CORONARY ARTERY DISEASE |
20 |
0.0007 |
| 588 |
MIGRAINE |
63 |
0.0007 |
| 589 |
URINARY RETENTION |
22 |
0.0007 |
| 590 |
ABDOMINAL DISCOMFORT |
110 |
0.0007 |
| 591 |
PRODUCT QUALITY ISSUE |
89 |
0.0007 |
| 592 |
DECREASED APPETITE |
152 |
0.0007 |
| 593 |
CARDIOMEGALY |
8 |
0.0006 |
| 594 |
PYREXIA |
225 |
0.0006 |
| 595 |
SKIN CANCER |
14 |
0.0006 |
| 596 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
29 |
0.0006 |
| 597 |
ANHEDONIA |
17 |
0.0006 |
| 598 |
MUSCULOSKELETAL CHEST PAIN |
10 |
0.0006 |
| 599 |
ANKLE FRACTURE |
10 |
0.0006 |
| 600 |
WHITE BLOOD CELL COUNT DECREASED |
70 |
0.0006 |
| 601 |
FULL BLOOD COUNT DECREASED |
13 |
0.0006 |
| 602 |
HEPATIC STEATOSIS |
12 |
0.0006 |
| 603 |
BACK INJURY |
7 |
0.0006 |
| 604 |
HAEMATURIA |
22 |
0.0006 |
| 605 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
11 |
0.0006 |
| 606 |
SECRETION DISCHARGE |
8 |
0.0006 |
| 607 |
CELLULITIS |
32 |
0.0006 |
| 608 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
16 |
0.0006 |
| 609 |
HYPERGLYCAEMIA |
23 |
0.0006 |
| 610 |
BRONCHOSPASM |
9 |
0.0006 |
| 611 |
SKIN DISORDER |
21 |
0.0006 |
| 612 |
BLOOD BILIRUBIN INCREASED |
17 |
0.0006 |
| 613 |
HYPERTENSIVE CRISIS |
7 |
0.0006 |
| 614 |
PRODUCTIVE COUGH |
30 |
0.0006 |
| 615 |
RHEUMATOID ARTHRITIS |
71 |
0.0006 |
| 616 |
TYPE 2 DIABETES MELLITUS |
21 |
0.0006 |
| 617 |
NEPHROPATHY TOXIC |
7 |
0.0006 |
| 618 |
LYMPHOCYTE COUNT DECREASED |
11 |
0.0006 |
| 619 |
GASTROOESOPHAGEAL REFLUX DISEASE |
50 |
0.0006 |
| 620 |
DRUG ERUPTION |
11 |
0.0006 |
| 621 |
SKIN ULCER |
16 |
0.0006 |
| 622 |
FLUID OVERLOAD |
9 |
0.0006 |
| 623 |
APATHY |
9 |
0.0006 |
| 624 |
GALLBLADDER DISORDER |
11 |
0.0006 |
| 625 |
IMPAIRED DRIVING ABILITY |
7 |
0.0006 |
| 626 |
CHOLECYSTECTOMY |
7 |
0.0006 |
| 627 |
BLOOD CREATININE INCREASED |
40 |
0.0006 |
| 628 |
HEADACHE |
384 |
0.0006 |
| 629 |
FLUID RETENTION |
31 |
0.0006 |
| 630 |
TOOTH INFECTION |
8 |
0.0006 |
| 631 |
DYSGEUSIA |
45 |
0.0006 |
| 632 |
PHOTOSENSITIVITY REACTION |
10 |
0.0006 |
| 633 |
C-REACTIVE PROTEIN INCREASED |
22 |
0.0006 |
| 634 |
AGEUSIA |
15 |
0.0006 |
| 635 |
HYPOAESTHESIA |
90 |
0.0006 |
| 636 |
SWELLING |
56 |
0.0006 |
| 637 |
MEMORY IMPAIRMENT |
82 |
0.0006 |
| 638 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
10 |
0.0006 |
| 639 |
BLOOD COUNT ABNORMAL |
9 |
0.0006 |
| 640 |
CANDIDA INFECTION |
10 |
0.0006 |
| 641 |
FEEDING DISORDER |
12 |
0.0006 |
| 642 |
PERIPHERAL SWELLING |
91 |
0.0006 |
| 643 |
SYNCOPE |
59 |
0.0006 |
| 644 |
NEUTROPHIL COUNT DECREASED |
24 |
0.0006 |
| 645 |
CHOLECYSTITIS |
7 |
0.0006 |
| 646 |
SKIN DISCOLOURATION |
27 |
0.0006 |
| 647 |
WEIGHT DECREASED |
164 |
0.0006 |
| 648 |
HYPONATRAEMIA |
33 |
0.0006 |
| 649 |
STEVENS-JOHNSON SYNDROME |
13 |
0.0006 |
| 650 |
OROPHARYNGEAL PAIN |
54 |
0.0006 |
| 651 |
INJURY |
41 |
0.0006 |
| 652 |
MUSCLE SPASMS |
107 |
0.0006 |
| 653 |
MUSCULOSKELETAL DISCOMFORT |
10 |
0.0006 |
| 654 |
GASTROINTESTINAL DISORDER |
52 |
0.0006 |
| 655 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
17 |
0.0006 |
| 656 |
BASAL CELL CARCINOMA |
9 |
0.0006 |
| 657 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
41 |
0.0006 |
| 658 |
CARDIAC FAILURE CONGESTIVE |
46 |
0.0006 |
| 659 |
MASS |
8 |
0.0006 |
| 660 |
BLOOD PRESSURE DECREASED |
38 |
0.0006 |
| 661 |
INTENTIONAL PRODUCT MISUSE |
50 |
0.0006 |
| 662 |
COUGH |
160 |
0.0006 |
| 663 |
DYSURIA |
21 |
0.0006 |
| 664 |
DYSPEPSIA |
56 |
0.0006 |
| 665 |
PANCREATITIS |
30 |
0.0006 |
| 666 |
BALANCE DISORDER |
49 |
0.0006 |
| 667 |
PRODUCT DOSE OMISSION IN ERROR |
16 |
0.0006 |
| 668 |
DIABETES MELLITUS INADEQUATE CONTROL |
10 |
0.0006 |
| 669 |
COVID-19 |
99 |
0.0006 |
| 670 |
DIALYSIS |
8 |
0.0006 |
| 671 |
SINUS TACHYCARDIA |
8 |
0.0006 |
| 672 |
BONE PAIN |
33 |
0.0006 |
| 673 |
GENERAL PHYSICAL HEALTH DETERIORATION |
65 |
0.0006 |
| 674 |
EPISTAXIS |
42 |
0.0006 |
| 675 |
THERAPEUTIC RESPONSE DECREASED |
34 |
0.0006 |
| 676 |
RENAL DISORDER |
26 |
0.0006 |
| 677 |
BURNING SENSATION |
39 |
0.0006 |
| 678 |
MYELOSUPPRESSION |
20 |
0.0006 |
| 679 |
BLOOD POTASSIUM INCREASED |
9 |
0.0006 |
| 680 |
PRODUCT PRESCRIBING ISSUE |
12 |
0.0006 |
| 681 |
PRODUCT USE IN UNAPPROVED INDICATION |
136 |
0.0005 |
| 682 |
SKIN LESION |
15 |
0.0005 |
| 683 |
ASCITES |
16 |
0.0005 |
| 684 |
ILL-DEFINED DISORDER |
33 |
0.0005 |
| 685 |
BONE MARROW FAILURE |
11 |
0.0005 |
| 686 |
TRANSAMINASES INCREASED |
12 |
0.0005 |
| 687 |
RENAL INJURY |
16 |
0.0005 |
| 688 |
DEMENTIA |
15 |
0.0005 |
| 689 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
28 |
0.0005 |
| 690 |
ABDOMINAL DISTENSION |
56 |
0.0005 |
| 691 |
NODULE |
7 |
0.0005 |
| 692 |
BLOOD CHOLESTEROL INCREASED |
25 |
0.0005 |
| 693 |
HAEMORRHAGE INTRACRANIAL |
8 |
0.0005 |
| 694 |
ACCIDENTAL EXPOSURE TO PRODUCT |
55 |
0.0005 |
| 695 |
JOINT STIFFNESS |
14 |
0.0005 |
| 696 |
HYPOAESTHESIA ORAL |
8 |
0.0005 |
| 697 |
BACK PAIN |
123 |
0.0005 |
| 698 |
TACHYCARDIA |
47 |
0.0005 |
| 699 |
DEEP VEIN THROMBOSIS |
34 |
0.0005 |
| 700 |
AMNESIA |
34 |
0.0005 |
| 701 |
PULMONARY FIBROSIS |
10 |
0.0005 |
| 702 |
WHITE BLOOD CELL COUNT INCREASED |
20 |
0.0005 |
| 703 |
PRODUCT SUBSTITUTION ISSUE |
30 |
0.0005 |
| 704 |
PNEUMONIA ASPIRATION |
13 |
0.0005 |
| 705 |
DEVICE RELATED INFECTION |
8 |
0.0005 |
| 706 |
EXTRA DOSE ADMINISTERED |
21 |
0.0005 |
| 707 |
ORTHOSTATIC HYPOTENSION |
9 |
0.0005 |
| 708 |
FALL |
172 |
0.0005 |
| 709 |
PARAESTHESIA |
81 |
0.0005 |
| 710 |
DRUG TOXICITY |
7 |
0.0005 |
| 711 |
PULMONARY OEDEMA |
23 |
0.0005 |
| 712 |
ORAL HERPES |
10 |
0.0005 |
| 713 |
COLD SWEAT |
9 |
0.0005 |
| 714 |
LIP SWELLING |
17 |
0.0005 |
| 715 |
ARTHRALGIA |
212 |
0.0005 |
| 716 |
DEHYDRATION |
68 |
0.0005 |
| 717 |
THROMBOCYTOPENIA |
57 |
0.0005 |
| 718 |
BRADYCARDIA |
27 |
0.0005 |
| 719 |
GAIT INABILITY |
17 |
0.0005 |
| 720 |
ALTERED STATE OF CONSCIOUSNESS |
11 |
0.0005 |
| 721 |
RASH |
221 |
0.0005 |
| 722 |
URINARY INCONTINENCE |
15 |
0.0005 |
| 723 |
SEPTIC SHOCK |
22 |
0.0005 |
| 724 |
DIZZINESS |
252 |
0.0005 |
| 725 |
CLOSTRIDIUM DIFFICILE INFECTION |
11 |
0.0005 |
| 726 |
MEDICATION ERROR |
28 |
0.0005 |
| 727 |
ORAL DISCOMFORT |
7 |
0.0005 |
| 728 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
17 |
0.0005 |
| 729 |
INTERVERTEBRAL DISC PROTRUSION |
11 |
0.0005 |
| 730 |
HYPOMAGNESAEMIA |
7 |
0.0005 |
| 731 |
MUSCULOSKELETAL STIFFNESS |
44 |
0.0005 |
| 732 |
HAEMOPTYSIS |
14 |
0.0005 |
| 733 |
ADVERSE DRUG REACTION |
45 |
0.0005 |
| 734 |
HYPOTHYROIDISM |
16 |
0.0005 |
| 735 |
BLOOD PRESSURE FLUCTUATION |
12 |
0.0005 |
| 736 |
CONSTIPATION |
109 |
0.0005 |
| 737 |
DEVICE OCCLUSION |
7 |
0.0005 |
| 738 |
DEAFNESS |
13 |
0.0005 |
| 739 |
PRODUCT PHYSICAL ISSUE |
10 |
0.0005 |
| 740 |
MENTAL IMPAIRMENT |
12 |
0.0005 |
| 741 |
FATIGUE |
385 |
0.0005 |
| 742 |
RASH MACULO-PAPULAR |
11 |
0.0005 |
| 743 |
NASAL CONGESTION |
29 |
0.0005 |
| 744 |
INTENTIONAL DOSE OMISSION |
14 |
0.0005 |
| 745 |
ANGINA PECTORIS |
14 |
0.0005 |
| 746 |
CHOLELITHIASIS |
16 |
0.0005 |
| 747 |
HYPOACUSIS |
21 |
0.0005 |
| 748 |
HEART RATE IRREGULAR |
11 |
0.0005 |
| 749 |
PAIN IN EXTREMITY |
143 |
0.0005 |
| 750 |
VENTRICULAR TACHYCARDIA |
8 |
0.0005 |
| 751 |
PRODUCT AVAILABILITY ISSUE |
11 |
0.0005 |
| 752 |
NECK PAIN |
27 |
0.0005 |
| 753 |
DRUG EFFECT DECREASED |
26 |
0.0005 |
| 754 |
DYSPNOEA |
273 |
0.0005 |
| 755 |
LYMPHADENOPATHY |
17 |
0.0005 |
| 756 |
DYSSTASIA |
14 |
0.0005 |
| 757 |
PAIN |
294 |
0.0005 |
| 758 |
HYPOTENSION |
96 |
0.0005 |
| 759 |
SURGERY |
28 |
0.0005 |
| 760 |
INFLUENZA |
53 |
0.0005 |
| 761 |
ACUTE MYOCARDIAL INFARCTION |
14 |
0.0005 |
| 762 |
DIARRHOEA |
306 |
0.0005 |
| 763 |
PSYCHOTIC DISORDER |
14 |
0.0005 |
| 764 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
8 |
0.0005 |
| 765 |
DRY MOUTH |
38 |
0.0005 |
| 766 |
GAIT DISTURBANCE |
89 |
0.0005 |
| 767 |
ACCIDENTAL OVERDOSE |
17 |
0.0005 |
| 768 |
HEPATIC FAILURE |
14 |
0.0005 |
| 769 |
RENAL IMPAIRMENT |
39 |
0.0005 |
| 770 |
HAEMATOMA |
12 |
0.0005 |
| 771 |
SKIN FISSURES |
9 |
0.0005 |
| 772 |
ASTHENIA |
173 |
0.0005 |
| 773 |
PRURITUS |
176 |
0.0005 |
| 774 |
HIP ARTHROPLASTY |
7 |
0.0005 |
| 775 |
OSTEONECROSIS |
15 |
0.0005 |
| 776 |
DISEASE PROGRESSION |
54 |
0.0005 |
| 777 |
ILLNESS |
47 |
0.0005 |
| 778 |
POLLAKIURIA |
19 |
0.0005 |
| 779 |
WEIGHT INCREASED |
102 |
0.0005 |
| 780 |
CHEST PAIN |
84 |
0.0005 |
| 781 |
INTESTINAL OBSTRUCTION |
17 |
0.0005 |
| 782 |
PREGNANCY |
9 |
0.0004 |
| 783 |
SPINAL FRACTURE |
9 |
0.0004 |
| 784 |
HEPATOTOXICITY |
10 |
0.0004 |
| 785 |
LIVER FUNCTION TEST ABNORMAL |
13 |
0.0004 |
| 786 |
BRAIN FOG |
7 |
0.0004 |
| 787 |
GOUT |
8 |
0.0004 |
| 788 |
PRODUCT DOSE OMISSION |
29 |
0.0004 |
| 789 |
THROAT TIGHTNESS |
12 |
0.0004 |
| 790 |
VERTIGO |
27 |
0.0004 |
| 791 |
LEUKOPENIA |
22 |
0.0004 |
| 792 |
CYSTITIS |
14 |
0.0004 |
| 793 |
DEVICE DELIVERY SYSTEM ISSUE |
12 |
0.0004 |
| 794 |
NEPHROLITHIASIS |
20 |
0.0004 |
| 795 |
CHILLS |
51 |
0.0004 |
| 796 |
RESPIRATORY DISORDER |
13 |
0.0004 |
| 797 |
PRODUCT STORAGE ERROR |
38 |
0.0004 |
| 798 |
MUSCLE TWITCHING |
10 |
0.0004 |
| 799 |
DIVERTICULITIS |
12 |
0.0004 |
| 800 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
78 |
0.0004 |
| 801 |
ANAEMIA |
82 |
0.0004 |
| 802 |
RASH MACULAR |
15 |
0.0004 |
| 803 |
DRUG RESISTANCE |
11 |
0.0004 |
| 804 |
INSOMNIA |
114 |
0.0004 |
| 805 |
OXYGEN SATURATION DECREASED |
24 |
0.0004 |
| 806 |
PALPITATIONS |
50 |
0.0004 |
| 807 |
ANAPHYLACTIC SHOCK |
11 |
0.0004 |
| 808 |
MANIA |
7 |
0.0004 |
| 809 |
BLOOD SODIUM DECREASED |
8 |
0.0004 |
| 810 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
86 |
0.0004 |
| 811 |
THROAT IRRITATION |
19 |
0.0004 |
| 812 |
HYPOCALCAEMIA |
8 |
0.0004 |
| 813 |
BLOOD URINE PRESENT |
8 |
0.0004 |
| 814 |
EXPIRED PRODUCT ADMINISTERED |
14 |
0.0004 |
| 815 |
IMPAIRED WORK ABILITY |
9 |
0.0004 |
| 816 |
LIMB DISCOMFORT |
13 |
0.0004 |
| 817 |
FEELING JITTERY |
8 |
0.0004 |
| 818 |
NEUTROPENIA |
57 |
0.0004 |
| 819 |
GASTRITIS |
11 |
0.0004 |
| 820 |
DIABETIC KETOACIDOSIS |
10 |
0.0004 |
| 821 |
FACE OEDEMA |
7 |
0.0004 |
| 822 |
BLOOD GLUCOSE INCREASED |
78 |
0.0004 |
| 823 |
ABDOMINAL PAIN UPPER |
85 |
0.0004 |
| 824 |
HOT FLUSH |
31 |
0.0004 |
| 825 |
TREMOR |
68 |
0.0004 |
| 826 |
KIDNEY INFECTION |
8 |
0.0004 |
| 827 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
29 |
0.0004 |
| 828 |
FREQUENT BOWEL MOVEMENTS |
11 |
0.0004 |
| 829 |
ASTHMA |
46 |
0.0004 |
| 830 |
LABORATORY TEST ABNORMAL |
12 |
0.0004 |
| 831 |
ROAD TRAFFIC ACCIDENT |
17 |
0.0004 |
| 832 |
PNEUMONITIS |
11 |
0.0004 |
| 833 |
ALOPECIA |
79 |
0.0004 |
| 834 |
TREATMENT NONCOMPLIANCE |
22 |
0.0004 |
| 835 |
DYSPHAGIA |
38 |
0.0004 |
| 836 |
PREMATURE BABY |
12 |
0.0004 |
| 837 |
MENTAL STATUS CHANGES |
11 |
0.0004 |
| 838 |
DEPRESSION |
90 |
0.0004 |
| 839 |
ABDOMINAL PAIN |
92 |
0.0004 |
| 840 |
FEELING COLD |
11 |
0.0004 |
| 841 |
PRODUCT PREPARATION ERROR |
8 |
0.0004 |
| 842 |
PULMONARY EMBOLISM |
37 |
0.0004 |
| 843 |
TOOTHACHE |
7 |
0.0004 |
| 844 |
PERITONITIS |
8 |
0.0004 |
| 845 |
PELVIC PAIN |
7 |
0.0004 |
| 846 |
ERYTHEMA |
79 |
0.0004 |
| 847 |
CONFUSIONAL STATE |
62 |
0.0004 |
| 848 |
KNEE ARTHROPLASTY |
8 |
0.0004 |
| 849 |
GASTRIC DISORDER |
13 |
0.0004 |
| 850 |
ANXIETY |
107 |
0.0004 |
| 851 |
POOR QUALITY SLEEP |
8 |
0.0004 |
| 852 |
CHEST DISCOMFORT |
38 |
0.0004 |
| 853 |
FAECES DISCOLOURED |
8 |
0.0004 |
| 854 |
ADVERSE EVENT |
34 |
0.0004 |
| 855 |
MUSCULOSKELETAL DISORDER |
7 |
0.0004 |
| 856 |
LETHARGY |
21 |
0.0004 |
| 857 |
EMOTIONAL DISTRESS |
44 |
0.0004 |
| 858 |
RESPIRATORY DISTRESS |
10 |
0.0004 |
| 859 |
ERUCTATION |
7 |
0.0004 |
| 860 |
CARDIAC FAILURE |
29 |
0.0004 |
| 861 |
PROCEDURAL PAIN |
10 |
0.0004 |
| 862 |
URTICARIA |
60 |
0.0004 |
| 863 |
NAUSEA |
281 |
0.0004 |
| 864 |
CHROMATURIA |
8 |
0.0004 |
| 865 |
BLOOD GLUCOSE DECREASED |
17 |
0.0004 |
| 866 |
DISORIENTATION |
14 |
0.0004 |
| 867 |
HEART RATE INCREASED |
35 |
0.0004 |
| 868 |
FLATULENCE |
20 |
0.0004 |
| 869 |
MALAISE |
154 |
0.0004 |
| 870 |
HYPOGLYCAEMIA |
17 |
0.0004 |
| 871 |
INCORRECT DOSE ADMINISTERED |
80 |
0.0004 |
| 872 |
METABOLIC ACIDOSIS |
11 |
0.0003 |
| 873 |
ECZEMA |
18 |
0.0003 |
| 874 |
MUCOSAL INFLAMMATION |
9 |
0.0003 |
| 875 |
BODY TEMPERATURE INCREASED |
7 |
0.0003 |
| 876 |
PRODUCT PRESCRIBING ERROR |
8 |
0.0003 |
| 877 |
CEREBRAL HAEMORRHAGE |
12 |
0.0003 |
| 878 |
RASH ERYTHEMATOUS |
16 |
0.0003 |
| 879 |
HOSPITALISATION |
51 |
0.0003 |
| 880 |
VOMITING |
156 |
0.0003 |
| 881 |
HALLUCINATION, VISUAL |
7 |
0.0003 |
| 882 |
DRY SKIN |
44 |
0.0003 |
| 883 |
MYALGIA |
56 |
0.0003 |
| 884 |
EATING DISORDER |
7 |
0.0003 |
| 885 |
ANGER |
11 |
0.0003 |
| 886 |
PRURITUS GENERALISED |
7 |
0.0003 |
| 887 |
DEVICE DISLOCATION |
14 |
0.0003 |
| 888 |
EXPOSURE DURING PREGNANCY |
20 |
0.0003 |
| 889 |
DRUG INTERACTION |
51 |
0.0003 |
| 890 |
PSORIATIC ARTHROPATHY |
13 |
0.0003 |
| 891 |
LOSS OF CONSCIOUSNESS |
41 |
0.0003 |
| 892 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
9 |
0.0003 |
| 893 |
INFLUENZA LIKE ILLNESS |
26 |
0.0003 |
| 894 |
INTERNATIONAL NORMALISED RATIO INCREASED |
9 |
0.0003 |
| 895 |
DIABETES MELLITUS |
24 |
0.0003 |
| 896 |
FLUSHING |
32 |
0.0003 |
| 897 |
MULTIPLE SCLEROSIS |
15 |
0.0003 |
| 898 |
RASH PRURITIC |
17 |
0.0003 |
| 899 |
MOVEMENT DISORDER |
10 |
0.0003 |
| 900 |
CARDIO-RESPIRATORY ARREST |
13 |
0.0003 |
| 901 |
WITHDRAWAL SYNDROME |
13 |
0.0003 |
| 902 |
RASH GENERALISED |
8 |
0.0003 |
| 903 |
SOMNOLENCE |
62 |
0.0003 |
| 904 |
DYSPHONIA |
18 |
0.0003 |
| 905 |
PLASMA CELL MYELOMA |
12 |
0.0003 |
| 906 |
SHOCK |
7 |
0.0003 |
| 907 |
AGITATION |
22 |
0.0003 |
| 908 |
IRRITABILITY |
18 |
0.0003 |
| 909 |
CARDIAC DISORDER |
28 |
0.0003 |
| 910 |
FEAR |
8 |
0.0003 |
| 911 |
TRANSIENT ISCHAEMIC ATTACK |
10 |
0.0003 |
| 912 |
SKIN EXFOLIATION |
25 |
0.0003 |
| 913 |
ARRHYTHMIA |
14 |
0.0003 |
| 914 |
FEELING HOT |
18 |
0.0003 |
| 915 |
HALLUCINATION |
22 |
0.0003 |
| 916 |
UNEVALUABLE EVENT |
22 |
0.0003 |
| 917 |
FEMUR FRACTURE |
9 |
0.0003 |
| 918 |
HAEMATOCHEZIA |
16 |
0.0003 |
| 919 |
ANAPHYLACTIC REACTION |
16 |
0.0003 |
| 920 |
INJECTION SITE URTICARIA |
7 |
0.0003 |
| 921 |
DERMATITIS ATOPIC |
15 |
0.0003 |
| 922 |
DEPRESSED MOOD |
15 |
0.0003 |
| 923 |
HYPERSOMNIA |
8 |
0.0003 |
| 924 |
ABDOMINAL PAIN LOWER |
7 |
0.0003 |
| 925 |
GASTRIC CANCER |
7 |
0.0003 |
| 926 |
HAEMATEMESIS |
7 |
0.0003 |
| 927 |
INJECTION SITE BRUISING |
22 |
0.0003 |
| 928 |
CRYING |
10 |
0.0003 |
| 929 |
HEPATITIS |
7 |
0.0003 |
| 930 |
THROMBOSIS |
22 |
0.0003 |
| 931 |
MALIGNANT NEOPLASM PROGRESSION |
28 |
0.0003 |
| 932 |
HYPERHIDROSIS |
35 |
0.0003 |
| 933 |
THERAPEUTIC RESPONSE SHORTENED |
9 |
0.0003 |
| 934 |
DEVICE ISSUE |
24 |
0.0003 |
| 935 |
DYSARTHRIA |
10 |
0.0003 |
| 936 |
JAUNDICE |
7 |
0.0003 |
| 937 |
PAIN OF SKIN |
7 |
0.0003 |
| 938 |
EMOTIONAL DISORDER |
8 |
0.0003 |
| 939 |
PALLOR |
7 |
0.0003 |
| 940 |
NERVOUS SYSTEM DISORDER |
8 |
0.0003 |
| 941 |
SWOLLEN TONGUE |
8 |
0.0003 |
| 942 |
DEVICE LEAKAGE |
11 |
0.0003 |
| 943 |
MOOD SWINGS |
8 |
0.0003 |
| 944 |
INCORRECT DRUG ADMINISTRATION DURATION |
7 |
0.0002 |
| 945 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
9 |
0.0002 |
| 946 |
FEELING ABNORMAL |
59 |
0.0002 |
| 947 |
FOETAL EXPOSURE DURING PREGNANCY |
20 |
0.0002 |
| 948 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
7 |
0.0002 |
| 949 |
SEIZURE |
28 |
0.0002 |
| 950 |
DEVICE DIFFICULT TO USE |
16 |
0.0002 |
| 951 |
INJECTION SITE PRURITUS |
16 |
0.0002 |
| 952 |
CEREBROVASCULAR ACCIDENT |
40 |
0.0002 |
| 953 |
INJECTION SITE ERYTHEMA |
29 |
0.0002 |
| 954 |
NERVOUSNESS |
12 |
0.0002 |
| 955 |
HAEMORRHAGE |
24 |
0.0002 |
| 956 |
DRUG ADMINISTRATION ERROR |
7 |
0.0002 |
| 957 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
9 |
0.0002 |
| 958 |
MYOCARDIAL INFARCTION |
39 |
0.0002 |
| 959 |
DISTURBANCE IN ATTENTION |
12 |
0.0002 |
| 960 |
INJECTION SITE SWELLING |
17 |
0.0002 |
| 961 |
RESTLESSNESS |
8 |
0.0002 |
| 962 |
INJECTION SITE REACTION |
15 |
0.0002 |
| 963 |
INJECTION SITE MASS |
8 |
0.0002 |
| 964 |
PROSTATE CANCER |
17 |
0.0002 |
| 965 |
INJECTION SITE PAIN |
63 |
0.0002 |
| 966 |
ABNORMAL BEHAVIOUR |
8 |
0.0002 |
| 967 |
THERAPEUTIC RESPONSE UNEXPECTED |
9 |
0.0002 |
| 968 |
ACNE |
15 |
0.0002 |
| 969 |
NEOPLASM MALIGNANT |
13 |
0.0002 |
| 970 |
CONVULSION |
11 |
0.0002 |
| 971 |
UNDERDOSE |
14 |
0.0002 |
| 972 |
DRUG DOSE OMISSION BY DEVICE |
15 |
0.0002 |
| 973 |
SPEECH DISORDER |
10 |
0.0002 |
| 974 |
INJECTION SITE HAEMORRHAGE |
15 |
0.0002 |
| 975 |
DEATH |
157 |
0.0002 |
| 976 |
DRUG DOSE OMISSION |
29 |
0.0002 |
| 977 |
MULTIPLE SCLEROSIS RELAPSE |
12 |
0.0002 |
| 978 |
SKIN IRRITATION |
8 |
0.0002 |
| 979 |
COGNITIVE DISORDER |
8 |
0.0002 |
| 980 |
LUNG NEOPLASM MALIGNANT |
7 |
0.0002 |
| 981 |
TOXICITY TO VARIOUS AGENTS |
28 |
0.0002 |
| 982 |
SUICIDAL IDEATION |
15 |
0.0002 |
| 983 |
CARDIAC ARREST |
13 |
0.0002 |
| 984 |
THERAPY CESSATION |
8 |
0.0002 |
| 985 |
BREAST CANCER |
13 |
0.0001 |
| 986 |
PSORIASIS |
17 |
0.0001 |
| 987 |
OVERDOSE |
26 |
0.0001 |
| 988 |
SKIN BURNING SENSATION |
8 |
0.0001 |
| 989 |
DRUG WITHDRAWAL SYNDROME |
8 |
0.0001 |
| 990 |
DRUG DEPENDENCE |
12 |
0.0001 |